CSOOSE Immunotherapeutics
Disclosure information not submitted.
Novel agonist monoclonal antibody targeting GPCR to decrease neutrophil accumulation and initiate resolution of chronic inflammation
Friday, April 17, 20269:45 AM - 10:00 AM US ET